CoChat
Sign Up
Cited by 366

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Preformed albumin corona, a protective coating for nanoparticles based drug delivery system

Peng, Qiang, Zhang, Shu, Yang, Qin, Zhang, Ting, Wei, Xue-Qin, Jiang, Li, Zhang, Chao-Liang, Chen, Qian-Ming, Zhang, Zhi-Rong, Lin, Yun-Feng·2013·Biomaterials
DOI 10.1016/j.biomaterials.2013.07.102
Open this paper in CoChat — free account

Abstract

The non-specific interaction between nanoparticles (NPs) and plasma proteins occurs immediately after NPs enter the blood, resulting in the formation of the protein corona that thereafter replaces the original NPs and becomes what the organs and cells really see. Consequently, the in vivo fate of NPs and the biological responses to the NPs are changed. This is one substantial reason for the two main problems of the NPs based drug delivery system, i.e. nanotoxicity and rapid clearance of NPs from the blood after intravenous injection. Here, we demonstrate the successful application of the preformed albumin corona in inhibiting the plasma proteins adsorption and decreasing the complement activation, and ultimately in prolonging the blood circulation time and reducing the toxicity of the polymeric PHBHHx NPs. Since the interaction of proteins with various nano-materials and/or -particles is ubiquitous, pre-forming albumin corona has a great potential to be a versatile strategy for optimizing the NPs based drug delivery system.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2013.07.102

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 6 references

Research works printed but not linked: 26

  1. Tenne, 2006, Inorganic nanotubes and fullerene-like nanoparticles, Nat Nanotechnol, 1, 103, 10.1038/nnano.2006.62 · DOI
  2. Lalatsa, 2012, Amphiphilic poly(L-amino acids) – new materials for drug delivery, J Control Release, 161, 523, 10.1016/j.jconrel.2012.04.046 · DOI
  3. Peng, 2012, A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles, Biomaterials, 33, 1583, 10.1016/j.biomaterials.2011.10.072 · DOI
  4. Lalatsa, 2012, A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain, Mol Pharm, 9, 1665, 10.1021/mp300009u · DOI
  5. Peng, 2013, Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin, Acta Biomater, 9, 5063, 10.1016/j.actbio.2012.09.034 · DOI
  6. Chertok, 2011, Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers, Biomaterials, 32, 6245, 10.1016/j.biomaterials.2011.05.004 · DOI
  7. Zhao, 2012, Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend, Biomaterials, 33, 1948, 10.1016/j.biomaterials.2011.11.051 · DOI
  8. Bawa, 2011, Regulating nanomedicine – can the FDA handle it?, Curr Drug Deliv, 8, 227, 10.2174/156720111795256156 · DOI
  9. Peng, 2010, Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability, Mol Pharm, 7, 565, 10.1021/mp900274u · DOI
  10. Cedervall, 2007, Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles, Proc Natl Acad Sci U S A, 104, 2050, 10.1073/pnas.0608582104 · DOI · Paper page
  11. Lindman, 2007, Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity, Nano Lett, 7, 914, 10.1021/nl062743+ · DOI
  12. Cedervall, 2007, Detailed identification of plasma proteins adsorbed on copolymer nanoparticles, Angew Chem Int Ed Engl, 46, 5754, 10.1002/anie.200700465 · DOI
  13. Lynch, 2008, Protein-nanoparticle interactions, Nano Today, 3, 40, 10.1016/S1748-0132(08)70014-8 · DOI
  14. Mahmoudi, 2011, Protein-nanoparticle interactions: opportunities and challenges, Chem Rev, 111, 5610, 10.1021/cr100440g · DOI
  15. Monopoli, 2012, Biomolecular coronas provide the biological identity of nanosized materials, Nat Nanotechnol, 7, 779, 10.1038/nnano.2012.207 · DOI · Paper page
  16. Lundqvist, 2011, The evolution of the protein corona around nanoparticles: a test study, ACS Nano, 5, 7503, 10.1021/nn202458g · DOI · Paper page
  17. Lundqvist, 2008, Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts, Proc Natl Acad Sci U S A, 105, 14265, 10.1073/pnas.0805135105 · DOI · Paper page
  18. Ruh, 2012, Identification of serum proteins bound to industrial nanomaterials, Toxicol Lett, 208, 41, 10.1016/j.toxlet.2011.09.009 · DOI
  19. Clift, 2010, The effects of serum on the toxicity of manufactured nanoparticles, Toxicol Lett, 198, 358, 10.1016/j.toxlet.2010.08.002 · DOI
  20. Maiorano, 2010, Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response, ACS Nano, 4, 7481, 10.1021/nn101557e · DOI · Paper page
  21. Shang, 2007, Unfolding of ribonuclease A on silica nanoparticle surfaces, Nano Lett, 7, 1991, 10.1021/nl070777r · DOI
  22. Shemetov, 2012, Molecular interaction of proteins and peptides with nanoparticles, ACS Nano, 6, 4585, 10.1021/nn300415x · DOI
  23. Ehrenberg, 2009, The influence of protein adsorption on nanoparticle association with cultured endothelial cells, Biomaterials, 30, 603, 10.1016/j.biomaterials.2008.09.050 · DOI · Paper page
  24. Ge, 2011, Binding of blood proteins to carbon nanotubes reduces cytotoxicity, Proc Natl Acad Sci U S A, 108, 16968, 10.1073/pnas.1105270108 · DOI
  25. Wang, 2011, Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner, Nano Lett, 11, 4985, 10.1021/nl202940k · DOI
  26. Lesniak, 2012, Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells, ACS Nano, 6, 5845, 10.1021/nn300223w · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Peng, Q., Zhang, S., Yang, Q., Zhang, T., Wei, X.-Q., Jiang, L., Zhang, C.-L., Chen, Q.-M., Zhang, Z.-R., & Lin, Y.-F.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2013-11
Volume
34
Issue
33
Pages
8521-8530
ISSN
0142-9612
DOI
10.1016/j.biomaterials.2013.07.102
Cited by
366
References
6
Language
en
Licence
Funders
  • National Natural Science Foundation of China (81071273, 31170929)
  • Young Faculty Science Foundation of Sichuan University (2012SCU11100)
  • Foundation of State Key Laboratory of Oral Diseases (SKLODYISF2012-08)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review